Department of Respiratory Medicine, Zhongnan Hospital of Wuhan University, Wuhan, People's Republic of China.
Department of Allergology, Zhongnan Hospital of Wuhan University, Wuhan, People's Republic of China.
Am J Physiol Lung Cell Mol Physiol. 2021 Sep 1;321(3):L533-L544. doi: 10.1152/ajplung.00079.2020. Epub 2021 Jul 7.
Store-operated calcium entry (SOCE) is involved in the pathogenesis of airway inflammation and remodeling in asthma. Store-operated calcium entry-associated regulatory factor (SARAF) can downregulate SOCE. We sought to investigate the role of SARAF in the regulation of airway inflammation and remodeling in asthma mice models, as well as in the functional regulation of human airway smooth muscle cells (hASMCs). Balb/c mice were sensitized and challenged with ovalbumin to establish the asthma mice models. Mice were transfected with lentivirus, which expressed the gene + GFP (green fluorescence protein) or the negative control gene + GFP. Airway resistance was measured with the animal pulmonary function system. Airway inflammation and remodeling were evaluated via histological staining. In vitro cultured hASMCs were transfected with scrambled small interfering RNA (siRNA) or SARAF-specific siRNA, respectively. The proliferation, migration rate, hypertrophy, and SOCE activity of hASMCs were examined with Cell Counting Kit-8, wound healing test, bright field imaging, and Ca fluorescence imaging, respectively. SARAF expression was measured by quantitative real-time PCR. Asthma mice models showed decreased SARAF mRNA expression in the lungs. SARAF overexpression attenuated airway inflammation, resistance, and also remodeling. Downregulation of SARAF expression with siRNA promoted the proliferation, migration, hypertrophy, and SOCE activity in hASMCs. SARAF plays a protective role against airway inflammation and remodeling in asthma mice models by blunting SOCE; SARAF may also be a functional regulating factor of hASMCs.
钙库操纵性钙内流(SOCE)参与哮喘气道炎症和重塑的发病机制。钙库操纵性钙内流相关调节因子(SARAF)可下调 SOCE。我们旨在研究 SARAF 在哮喘小鼠模型中气道炎症和重塑的调节作用,以及在人气道平滑肌细胞(hASMCs)功能调节中的作用。Balb/c 小鼠用卵清蛋白致敏和激发,建立哮喘小鼠模型。用表达基因+GFP(绿色荧光蛋白)或阴性对照基因+GFP 的慢病毒转染小鼠。用动物肺功能系统测量气道阻力。通过组织学染色评估气道炎症和重塑。体外培养的 hASMCs 分别用乱序小干扰 RNA(siRNA)或 SARAF 特异性 siRNA 转染。用细胞计数试剂盒-8 检测 hASMCs 的增殖、迁移率、肥大和 SOCE 活性,用划痕愈合试验、明场成像和 Ca 荧光成像分别检测。用实时定量 PCR 检测 SARAF 表达。哮喘小鼠模型中肺组织 SARAF mRNA 表达降低。SARAF 过表达可减轻气道炎症、阻力和重塑。用 siRNA 下调 SARAF 表达可促进 hASMCs 的增殖、迁移、肥大和 SOCE 活性。SARAF 通过抑制 SOCE 在哮喘小鼠模型中发挥气道炎症和重塑的保护作用;SARAF 也可能是 hASMCs 的功能调节因子。